Drug Approval | April 14, 2025
Aurobindo receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
The product will be launched in Q1FY26
The product will be launched in Q1FY26
The supply of these goods is set to commence within the first quarter of FY26
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial) have an estimated market size of US$ 48 million for twelve months ending December 2024 according to IQVIA
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
PRX-PLUS has a unique product feature with its deep-impacting formula
AstraZeneca Pharma India discontinues manufacturing of Imdur
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851
Subscribe To Our Newsletter & Stay Updated
